Bio-Techne (TECH) just put investors on notice with a conditional quarterly dividend of $0.08 per share, tied directly to its ...

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, ...

Bio-Techne Corporation ( TECH) reported that its first quarter net earnings declined to $28.29 million or $0.18 per share from $38.19 million or $0.24 per share last year. Operating income for the ...

Bio-Techne stock traded at EUR 64.94 on Lang & Schwarz at 11:00 p.m. CET on Wednesday, November 4, 2026. The company operates ...

Bio-Techne Corporation (TECH) is a Minnesota-based life sciences company with a 50-year history of serving the scientific research and diagnostics industries. The company develops and supplies ...

Develops and manufactures life science reagents, analytical instruments, and diagnostic products, including proteins, antibodies, assays, and molecular diagnostic kits Generates revenue through the ...

Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended September 30, 2026. The quarterly dividend will be ...

Detailed price information for Bio-Techne Corp (TECH-Q) from The Globe and Mail including charting and trades.

Science Based Targets initiative validates Bio-Techne's Scope 1, 2 and 3 greenhouse gas reduction targets Market-based Scope 1 and 2 emissions reduced 49% year-over-year More than half of the ...

The DCF model implemented in this article suggests that Bio-Techne is overvalued by 34.53%. Bio-Techne has allocated significant financial resources to capex. Due to these resources, its revenues ...

Bio-Techne (ISIN US09073M1045) has its next quarterly reporting date scheduled for November 4, 2026, according to MarketBeat.